Arzu Didem Yalçın - Concepedia

Author

Arzu Didem Yalçın

Also Known As

A D Yalcin, A Didem Yalcin, A.D. Yalcin, A.D. Yalçin, AD Yalcin, Arzu D Yalcin, Arzu D. Yalcin, Arzu Didem YALÇIN, Arzu Didem Yalcin, Arzu Didem Yalcın

118

Publications

918

Citations

H-Index

Concepts

All Affiliations

Antalya Eğitim ve Araştırma Hastanesi Akdeniz University Heidelberg University Dokuz Eylül University German Cancer Research Center

About

Arzu Didem Yalçın is an author at Antalya Eğitim ve Araştırma Hastanesi specializing in medicine, cancer research, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	70
2	Immunology	2	2	22
3	Allergy	1	1	25
4	Allergy Medicine	1	1	25
5	Hospital Medicine	1	1	23

Arzu Didem Yalçın

Publications

425

Citations

H-Index

Page 1

	Year	Citations
A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels Arzu Didem Yalçın Immunopharmacology and Immunotoxicology	2015	57
Omalizumab (anti-IgE) therapy in the asthma–COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels Arzu Didem Yalçın Immunopharmacology and Immunotoxicology	2016	57
D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment Arzu Didem Yalçın, Betül Çelik, Saadet Gümüşlü Expert Opinion on Biological Therapy	2013	34
Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels Arzu Didem Yalçın, Aykut Çilli, Ludwig G. Strauss, Expert Opinion on Biological Therapy	2013	26
Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1<b>β</b>and sCD200 in cases of Samter's syndrome: 36 months follow-up Arzu Didem Yalçın, Seçil Uçar, Saadet Gümüşlü, Immunopharmacology and Immunotoxicology	2013	25
Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps Diego Bagnasco, Rikki Frank Canevari, Stefano Del Giacco, World Allergy Organization Journal AsthmaNasal PolypsAllergyAutoimmune DiseaseAllergy Medicine	2022	25
Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone Ruşen Uzun, Arzu Didem Yalçın, Betül Çelik, American Journal of Case Reports	2016	24
Perioperative antibiotic prophylaxis and cost in a Turkish University Hospital. Ata Nevzat Yalçın, Rıza Hakan Erbay, Simay Serin, PubMed Surgical ProceduresAntibiotic AdjuvantSurgeryDrug ResistanceHospital Medicine	2007	23
Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial Arzu Yorgancıoğlu, Ferda Öner Erkekol, Dilşad Mungan, International Archives of Allergy and Immunology	2018	22
Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis Arzu Didem Yalçın, Saadet Gümüşlü, Gizem Esra Parlak, Immunopharmacology and Immunotoxicology	2012	21

Page 1